back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-03-11 14:06 Tx date 2023-12-31 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Donley, Matthew
5 - Senior Officer of Issuer
Direct Ownership
|
Options
38 - Redemption, retraction, cancellation, repurchase
|
-126,500 vol |
665,015 | |
| Filed 2025-03-05 13:04 Tx date 2025-02-28 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Donley, Matthew
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$954,440
+126,416 vol $7.55 each |
917,931 | |
| Filed 2025-03-05 13:02 Tx date 2025-03-03 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Donley, Matthew
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Performance Award
57 - Exercise of rights
|
$-542,256
-67,782 vol $8.00 each |
150,566 | |
| Filed 2025-03-05 12:59 Tx date 2025-03-03 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Donley, Matthew
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Performance Award
56 - Grant of rights
|
+135,567 vol |
218,348 | |
| Filed 2025-03-05 12:58 Tx date 2025-02-28 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Donley, Matthew
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Performance Award
56 - Grant of rights
|
+82,781 vol |
82,781 | |
| Filed 2025-03-05 12:56 Tx date 2025-03-04 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Donley, Matthew
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
57 - Exercise of rights
|
$-715,793.76
-90,378 vol $7.92 each |
234,822 | |
| Filed 2025-03-05 12:55 Tx date 2025-03-04 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Donley, Matthew
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
57 - Exercise of rights
|
$-274,776.48
-34,694 vol $7.92 each |
325,200 | |
| Filed 2025-03-05 12:52 Tx date 2025-03-03 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Donley, Matthew
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
57 - Exercise of rights
|
$-577,776
-72,222 vol $8.00 each |
359,894 | |
| Filed 2025-03-05 12:47 Tx date 2025-03-04 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Donley, Matthew
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+47,751 vol |
295,077 | |
| Filed 2025-03-05 12:46 Tx date 2025-03-04 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Donley, Matthew
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+18,330 vol |
247,326 | |
| Filed 2025-03-05 12:44 Tx date 2025-03-03 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Donley, Matthew
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+35,876 vol |
228,996 | |
| Filed 2025-03-05 12:42 Tx date 2025-03-03 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Donley, Matthew
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+38,226 vol |
193,120 | |
| Filed 2025-03-05 12:40 Tx date 2025-02-28 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Donley, Matthew
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
+2,938 vol |
154,894 | |
| Filed 2024-03-08 11:20 Tx date 2024-03-06 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Donley, Matthew
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
57 - Exercise of rights
|
$-497,982.78
-90,378 vol $5.51 each |
432,116 | |
| Filed 2024-03-08 11:19 Tx date 2024-03-06 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Donley, Matthew
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
57 - Exercise of rights
|
$-191,158.43
-34,693 vol $5.51 each |
522,494 | |
| Filed 2024-03-08 10:48 Tx date 2024-03-06 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Donley, Matthew
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+61,087 vol |
151,956 | |
| Filed 2024-03-08 10:48 Tx date 2024-03-06 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Donley, Matthew
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+23,319 vol |
90,869 | |
| Filed 2024-03-08 10:45 Tx date 2024-03-06 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Donley, Matthew
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
57 - Exercise of rights
|
$-506,116.80
-90,378 vol $5.60 each |
432,116 | |
| Filed 2024-03-08 10:45 Tx date 2024-03-06 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Donley, Matthew
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
57 - Exercise of rights
|
$-506,116.80
-90,378 vol $5.60 each |
||
| Filed 2024-03-08 10:44 Tx date 2024-03-06 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Donley, Matthew
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
57 - Exercise of rights
|
$-194,280.80
-34,693 vol $5.60 each |
||
| Filed 2024-03-08 10:44 Tx date 2024-03-06 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Donley, Matthew
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
57 - Exercise of rights
|
$-194,280.80
-34,693 vol $5.60 each |
522,494 | |
| Filed 2024-02-26 10:38 Tx date 2024-02-20 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Donley, Matthew
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$24,304,900
+4,930 vol $4,930 each |
67,550 | |
| Filed 2024-02-26 10:37 Tx date 2024-02-20 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Donley, Matthew
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
56 - Grant of rights
|
+216,666 vol |
557,187 | |
| Filed 2023-03-07 10:40 Tx date 2023-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Donley, Matthew
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+34,693 vol |
62,620 | |
| Filed 2023-03-07 10:38 Tx date 2023-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Donley, Matthew
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
57 - Exercise of rights
|
-34,693 vol |
340,521 | |
| Filed 2023-03-07 10:37 Tx date 2023-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Donley, Matthew
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
56 - Grant of rights
|
+271,134 vol |
375,214 | |
| Filed 2022-11-23 16:05 Tx date 2022-11-21 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Donley, Matthew
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
+1,703 vol |
27,927 | |
| Filed 2022-11-23 16:04 Tx date 2022-11-21 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Donley, Matthew
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$46,600
+10,000 vol $4.66 each |
26,224 | |
| Filed 2022-03-07 16:57 Tx date 2022-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Donley, Matthew
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+5,448 vol |
16,224 | |
| Filed 2022-03-07 16:51 Tx date 2022-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Donley, Matthew
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Performance Award
57 - Exercise of rights
|
$-102,085
-8,500 vol $12.01 each |
0 | |
| Filed 2022-03-07 16:47 Tx date 2022-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Donley, Matthew
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Performance Award
58 - Expiration of rights
|
-34,000 vol |
8,500 | |
| Filed 2022-03-07 15:04 Tx date 2022-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Donley, Matthew
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
56 - Grant of rights
|
+104,080 vol |
104,080 | |
| Filed 2022-03-07 15:00 Tx date 2019-07-17 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Donley, Matthew
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-03-07 12:42 Tx date 2022-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Donley, Matthew
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
+876 vol |
10,776 | |
| Filed 2022-03-07 10:55 Tx date 2022-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Donley, Matthew
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$2,138,536
+178,063 vol $12.01 each |
791,515 | |
| Filed 2021-05-12 17:26 Tx date 2021-05-11 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Donley, Matthew
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$99,693
+9,900 vol $10.07 each |
9,900 | |
| Filed 2021-05-12 17:25 Tx date 2019-07-17 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Donley, Matthew
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-12-23 18:34 Tx date 2020-12-21 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Donley, Matthew
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$3,087,484
+236,952 vol $13.03 each |
613,452 | |
| Filed 2020-10-26 17:20 Tx date 2020-10-23 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Donley, Matthew
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Performance Award
56 - Grant of rights
|
+42,500 vol |
42,500 | |
| Filed 2020-10-26 17:19 Tx date 2019-07-17 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Donley, Matthew
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Performance Award
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-10-26 17:19 Tx date 2020-01-28 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Donley, Matthew
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$3,063,830
+126,500 vol $24.22 each |
376,500 | |
| Filed 2020-10-26 17:17 Tx date 2019-08-19 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Donley, Matthew
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,962,500
+250,000 vol $7.85 each |
250,000 | |
| Filed 2020-10-26 17:16 Tx date 2019-07-17 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Donley, Matthew
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|